UN’s FDA approved J&J’s Spravato nasal spray for treating major depression disorder
The Food and Drug Administration of the United Nations approved Johnson & Johnson’s Spravato nasal spray for treating major depression disorder. According to the approval of the drug, the prescription is for a stand-alone treatment. The breakthrough medicine will target